V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005228 | 280003396 | null | 64.8 | Palliative (P) | 2014-12-17 | 2015-02-02 | ECF | N | N | 280028738 | LANREOTIDE |
| 280005229 | 280003396 | 1.68 | null | Curative (C) | 2014-04-08 | 2014-04-21 | DE-ESCALATE TRIAL | null | N | 280028738 | CISPLATIN + ETOPOSIDE |
| 280005230 | 280003397 | 1.62 | 51.6 | Palliative (P) | 2013-11-11 | 2013-11-15 | VAC | Y | N | 280028742 | LANREOTIDE |
| 280005231 | 280003397 | 1.57 | 49 | Palliative (P) | 2017-01-01 | 2017-01-02 | Erlotinib | 2 | N | 280028742 | OXALIPLATIN + MDG |
| 280005232 | 280003398 | 1.61 | 48.8 | Palliative (P) | null | 2016-05-21 | Capecitabine + Oxaliplatin 21day | N | N | 280028745 | CISPLATIN + ETOPOSIDE |
| 280005233 | 280003399 | 1.72 | 70 | Curative (C) | 2015-05-27 | 2015-06-09 | Oxaliplatin + Modified de Gramont | 02 | N | 280028746 | BEP |
| 280005234 | 280007779 | 1.69 | null | Palliative (P) | 2016-09-15 | 2016-09-16 | Trabectedin | 02 | N | 280028748 | CISPLATIN + ETOPOSIDE |
| 280005235 | 280007779 | 1.71 | 78 | Neo-adjuvant (N) | 2013-04-10 | 2013-04-24 | Cyclophosphamide + Vincristine | 2 | N | 280028748 | ECX |
| 280005236 | 280003400 | 1.7 | 89.2 | Palliative (P) | 2014-09-02 | 2014-09-26 | OCTREOTIDE | N | N | 280028751 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280005237 | 280003401 | null | null | Palliative (P) | null | 2013-10-08 | LANREOTIDE | null | null | 280028752 | OXALIPLATIN + MDG |
| 280005238 | 280003401 | 1.75 | 88.9 | Palliative (P) | 2013-07-17 | 2013-07-17 | EW EuroEwing 99 : VIDE | N | N | 280028752 | CISPLATIN + ETOPOSIDE |
| 280005239 | 280003401 | 1.84 | 107 | Palliative (P) | 2015-01-03 | 2015-01-04 | Capecitabine + Cisplatin | N | N | 280028752 | OXALIPLATIN + MDG |
| 280005240 | 280003401 | 1.68 | 84.5 | Palliative (P) | 2017-09-02 | 2017-09-08 | Doxorubicin + Olaratumab | 02 | N | 280028752 | ECX |
| 280005241 | 280011590 | 1.62 | 66 | Palliative (P) | 2014-03-27 | 2014-03-30 | DABRAFENIB | N | N | 280028765 | BEVACIZUMAB + IRINOTECAN + MdG |
| 280005242 | 280011848 | 1.83 | null | null | 2015-07-26 | 2015-08-02 | ETOPOSIDE | N | N | 280028766 | OXALIPLATIN + MDG |
| 280005243 | 280011848 | null | 76.2 | Curative (C) | 2017-10-31 | 2017-11-17 | Carbo F | N | N | 280028766 | CISPLATIN + FLUOROURACIL + RT |
| 280005244 | 280003402 | 1.82 | 68.2 | Palliative (P) | 2018-05-12 | 2018-06-11 | CARBOPLATIN + GEMCITABINE | N | N | 280028769 | ECX |
| 280005245 | 280003402 | 1.71 | 62 | Palliative (P) | 2016-12-31 | 2017-01-04 | Ipilimumab | 2 | N | 280028769 | CISPLATIN + PEMETREXED |
| 280005246 | 280003402 | 1.79 | null | Palliative (P) | 2014-05-26 | 2014-05-27 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | N | N | 280028769 | FLUOROURACIL + MITOMYCIN |
| 280005247 | 280003403 | null | 81.1 | Palliative (P) | 2016-01-27 | 2016-02-01 | Capecitabine (21days) + Carboplatin | null | null | 280028773 | CARBOPLATIN + PEMETREXED |
| 280005248 | 280003403 | 1.67 | 75.9 | Palliative (P) | 2016-09-25 | 2016-10-15 | Capecitabine (21days) + Carboplatin | N | N | 280028773 | CAPECITABINE |
| 280005249 | 280003404 | 1.55 | 57.9 | Palliative (P) | 2017-09-23 | 2017-09-26 | FCiSt | 2 | N | 280028776 | IPILIMUMAB + NIVOLUMAB |
| 280005250 | 280003404 | 1.75 | 95 | Palliative (P) | 2013-10-10 | 2013-10-10 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 280028776 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280005251 | 280003405 | 1.64 | 57 | Curative (C) | 2015-11-03 | 2015-11-23 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280028780 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + ETOPOSIDE + VINCRISTINE |
| 280005252 | 280007784 | 1.72 | 65.4 | Palliative (P) | null | 2014-01-24 | Cisplatin + Fluorouracil + RT 5day | N | N | 280028781 | CARBOPLATIN + PEMETREXED |
| 280005253 | 280007784 | 1.71 | 71.4 | Palliative (P) | 2014-11-01 | 2015-10-27 | PACLITAXEL | N | N | 280028781 | OCTREOTIDE |
| 280005254 | 280007784 | 1.84 | 58.4 | Palliative (P) | null | 2016-03-30 | Oxaliplatin + Modified de Gramont | null | null | 280028781 | CAPECITABINE + OXALIPLATIN |
| 280005255 | 280003406 | 1.57 | 70.6 | Palliative (P) | 2014-04-02 | 2014-04-18 | VIDE | N | N | 280028785 | FLUOROURACIL + STREPTOZOCIN |
| 280005256 | 280003406 | 1.54 | 76.2 | Palliative (P) | 2014-06-16 | 2014-06-18 | CARBOPLATIN + GEMCITABINE | N | N | 280028785 | CAPECITABINE |
| 280005257 | 280003406 | 1.47 | null | Palliative (P) | 2016-06-24 | 2016-07-11 | LIPOSOMAL DOXORUBICIN | N | N | 280028785 | ECX |
| 280005258 | 280003406 | 1.62 | 102 | Curative (C) | 2017-03-10 | 2017-03-10 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280028785 | ADE |
| 280005259 | 280003407 | 1.8 | 79.6 | Palliative (P) | 2015-03-10 | 2015-03-10 | LIPOSOMAL DOXORUBICIN | N | N | 280028791 | DABRAFENIB |
| 280005260 | 280003407 | 1.51 | 44.5 | Palliative (P) | 2014-04-11 | 2014-04-21 | Oxaliplatin + Modified de Gramont | N | N | 280028791 | ECX |
| 280005261 | 280009977 | 1.61 | 40.2 | Palliative (P) | 2016-10-12 | 2016-10-12 | Capecitabine (14 days)+Carboplatin | 02 | N | 280028794 | OXALIPLATIN + MDG |
| 280005262 | 280003408 | null | 0 | Palliative (P) | 2015-02-28 | 2015-02-28 | Liposomal Doxorubicin (Caelyx) | 02 | null | 280028795 | GEMCARBO |
| 280005263 | 280003408 | 1.82 | 21.3 | Palliative (P) | null | 2014-10-14 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028795 | ECF |
| 280005264 | 280003408 | 1.71 | 71.2 | Palliative (P) | 2015-09-12 | 2015-09-25 | Gemcitabine weekly | 02 | N | 280028795 | GEMCITABINE |
| 280005265 | 280003408 | null | 88 | Palliative (P) | 2015-10-19 | 2015-10-23 | Cisplatin + Vinorelbine (IV) | Y | N | 280028795 | GEMCARBO |
| 280005266 | 280003409 | 1.63 | 53.8 | Disease modification (D) | 2015-04-20 | 2015-05-10 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 280028801 | IRINOTECAN + MDG |
| 280005267 | 280003410 | 1.58 | null | null | 2015-12-02 | 2016-01-01 | Etoposide + Ifosfamide (3 days) | N | Y | 280028802 | GEMCITABINE |
| 280005268 | 280003410 | 1.72 | 75.8 | Palliative (P) | 2015-05-24 | 2015-05-24 | Ipilimumab | 02 | null | 280028802 | EVEROLIMUS |
| 280005269 | 280003410 | 1.8 | 76 | Curative (C) | 2013-06-17 | 2013-06-21 | ABVD | N | null | 280028802 | CISPLATIN + VINORELBINE |
| 280005270 | 280003410 | 1.77 | 74 | Palliative (P) | 2014-07-16 | 2014-07-21 | Mitomycin Intravesical | 02 | N | 280028802 | GEMCARBO |
| 280005271 | 280003410 | 1.73 | 80.8 | Palliative (P) | 2015-03-27 | 2015-04-09 | GEMCARBO | N | N | 280028802 | ECX |
| 280005272 | 280003411 | 1.69 | 70.9 | Palliative (P) | 2016-04-21 | 2016-04-30 | LIPOSOMAL DOXORUBICIN | N | N | 280028808 | MPT |
| 280005273 | 280007789 | 1.54 | 59.5 | Palliative (P) | 2017-03-12 | 2017-03-23 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | n | 280028809 | VEMURAFENIB |
| 280005274 | 280007789 | 1.78 | 85.7 | Palliative (P) | null | 2014-01-07 | Gemcitabine 1000mg/m2 D1 8 15 | null | null | 280028809 | CAPECITABINE + OXALIPLATIN |
| 280005275 | 280007789 | 1.69 | 78 | Curative (C) | 2014-11-21 | 2014-12-01 | Trabectedin | N | N | 280028809 | IPM |
| 280005276 | 280003412 | 1.83 | 77.8 | Palliative (P) | 2014-07-02 | 2014-07-06 | VIDE | 02 | N | 280028813 | CAPECITABINE + OXALIPLATIN |
| 280005277 | 280003412 | 1.88 | 65.4 | Palliative (P) | 2013-08-20 | 2013-09-02 | LANREOTIDE | 02 | N | 280028813 | CARBOPLATIN + VINORELBINE |